Xeris Pharmaceuticals Inc (NASDAQ:XERS)
| 2.42 Delayed Data As of Sep 21 |  +0.06 / +2.53%Today’s Change | 2.16 Today|||52-Week Range 7.94 | -50.81% Year-to-Date |
Latest XERS News | Press Releases
No recent news for Xeris Pharmaceuticals Inc.
Today’s Trading
| Previous close | 2.37 |
| Today’s open | 2.37 |
| Day’s range | 2.37 - 2.47 |
| Volume | 832,441 |
| Average volume (3 months) | 3,887,105 |
| Market cap | $170.2M |
Data as of 4:00pm ET, 09/21/2021
Growth & Valuation
| Earnings growth (last year) | +55.56% |
| Earnings growth (this year) | +34.74% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +650.73% |
| P/E ratio | NM |
| Price/Sales | 10.27 |
| Price/Book | 4.52 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| AQSTAquestive Therapeuti... | +0.18 | +4.46% |
| EDSAEdesa Biotech Inc | -3.56 | -29.87% |
| ATNMActinium Pharmaceuti... | +0.70 | +9.46% |
| SLSSellas Life Sciences... | +0.19 | +1.94% |
Data as of 5:44pm ET, 09/21/2021
Financials
| Next reporting date | November 11, 2021 |
| EPS forecast (this quarter) | -$0.36 |
| Annual revenue (last year) | $20.4M |
| Annual profit (last year) | -$91.1M |
| Net profit margin | -446.00% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Chicago, Illinois |
Forecasts
